Matthew Roe named executive director of Colorado Prevention Center

August 2, 2017 – Roe has been a member of the DCRI since 1999.

The DCRI’s Matthew Roe, MD, MHS, has been named executive director of the Colorado Prevention Center and Professor of Medicine at the University of Colorado’s School of Medicine. Roe will begin his new position on January 1, 2018.

Roe currently serves as faculty director of Megatrials, director of the DCRI Research Fellowship, and faculty director of the DCRI Think Tank Series. In 2008 he received the Robert M. Califf Mentorship Award, given to a faculty member who has demonstrated excellence in mentorship activities for DCRI research fellows.

Roe is also the co-principal investigator for the ADAPTABLE Trial (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness), which is a trial evaluating aspirin dose in more than 20,000 patients at high risk for cardiovascular disease. He is the previous chair of the Research and Publications Sub-Committee for the American College of Cardiology (ACC) ACTION Registry-GWTG program evaluating care patterns for patients with acute MI.

Roe serves as a member of the ACC National Cardiovascular Data Registry Scientific Oversight Committee and the American Heart Association (AHA) Mission Lifeline Scientific Task Force. He has been the DCRI principal investigator for the Data Analytic Center activities for the ACC-NCDR Cath PCI Registry, the ACTION Registry-GWTG Program, and the AHA Mission Lifeline program.

“I’m deeply appreciative of the many opportunities that I’ve had at the DCRI and Duke that allowed me to successfully pursue this position,” Roe said. “The mentorship and friendships that I’ve been fortunate to have at the DCRI, especially Eric Peterson and Lisa Berdan, has defined my career and will strongly influence my future at Colorado.”

Roe received his medical degree and his Masters of Health Sciences in Clinical Research from Duke University School of Medicine. He completed an internal medicine residency at Duke University Medical Center and a cardiovascular fellowship at the Cleveland Clinic Foundation.